2021 REBPI Conference Abstract Submission Guidelines

CALL FOR ABSTRACTS 

Abstract Submission Deadline EXTENDED: July 11, 2021 (11:59 pm Pacific Time)

You are invited to submit abstracts for the 19th Annual Research, Evidence-Based Practice and Innovation Conference.

To submit your abstract, please complete the online abstract submission form and supply all required information. 

2021 ABSTRACT SUBMISSION FORM

SUBMISSION GUIDELINES

Please read all instructions below before beginning your abstract submission.

Eligibility Criteria 

• Completed, works-in-progress, and previously presented/published studies and projects are welcome.
• Abstracts may be submitted to one of the following categories: research, innovation, evidence-based practice, or quality improvement.
• Abstracts may be considered for one of the following presentation formats: oral (podium) presentation, poster presentation or either oral/poster presentation.
• In-progress and completed projects will be eligible for poster presentation. Posters will be presented during a virtual poster session.
• Oral presentations will be reserved for projects with completed results. Virtual oral presentations will be allotted approximately 10 minutes, with five (5) minutes for audience questions.
• Incomplete and late submissions will not be accepted.
• Two authors may present if the abstract is accepted. One author must be identified as the primary presenting author and will be the point of contact for all communications regarding the abstract, and is responsible for communication with other authors.
• Submission of an abstract constitutes a commitment by the author(s) to present if accepted.

Abstract Submission Content

Please use the abstract submission form portal and follow all instructions to upload your abstract. All abstracts should be prepared as a Microsoft Word document.

Submissions must include the following:

Learning Objectives

• Short, compelling description of the session by providing up to two (2) learning objectives.
• Describes what participants should expect to learn by attending your session.
• Objectives are action-oriented, measurable, and achievable.
• Limit 200 characters, excluding spaces.
• May be included in promotional materials such as conference brochures or program, if accepted.

Abstract 

• Limit 500 words (excludes title, learning objective, and references)
• Contains no personal or organizational identifiers (abstracts with identifiers will be disqualified and ineligible for selection)
• Organize the body of your abstract to include the following headings/components:

Research - Generation of new knowledge using a quantitative or qualitative design pertaining to various relevant topics and practice settings. Note: Systematic reviews, methodology papers, and concept analyses will be evaluated according to research abstract criteria. (Research Abstract Template)

• Background/Significance: Description of the problem and significance.
• Purpose/Aim: Research question(s), specific aim(s), and hypothesis.
• Methods: Theoretical framework and study design and methods, including a description of setting, sample, procedures, instruments/measures, and statistical/data analysis.
• Results: Specific results in summary form.
• Conclusions/Implications for Practice: Major findings are presented with interpretation/ implications for clinical practice, contribution to the body of knowledge, and/or recommendations for future directions.

Evidence-Based Practice (EBP) - Translation of evidence into practice (practice change). Note: Case studies and literature reviews will be evaluated according to EBP abstract criteria. (EBP Abstract Template)

• Background/Significance: Summary of the issue(s), problem, or specific clinical challenges or controversy, with relevant background and contextual information. Evidence synthesis and strength of the evidence that supports the project/initiative.
• Purpose/EBP Question: Searchable (PICOT) question and statement of purpose for the project/initiative.
• Implementation Plan/Methods: Project/initiative description of the recommended practice change, clinical intervention(s), criteria/plan used to guide evaluation of change. Include implementation strategies to describe how the changes were made.
• Results/Outcomes: Brief description of the outcomes of practice change.
• Conclusions/Implications for Practice: Brief description of lessons learned, dissemination plan, and next steps (e.g., sustainability plan).

Quality Improvement (QI) - Implementation of process and performance methods to improve quality, safety, effectiveness, patient-centeredness, timeliness, cost, efficiency, access, and equity in healthcare (QI Abstract Template)

• Background/Significance: Statement of the problem; evidence synthesis and strength of the evidence that supports the project/initiative.
• Purpose/Goal: Statement of purpose/goal for the project/initiative.
• Implementation Plan/Methodology: Describe use of quality improvement method (e.g. Lean, PDCA/PDSA, Six Sigma) with identified and measurable outcomes or goals. Fully define the "who, what, when, where and how" of the project implementation. Instruments/measures, data collection procedures, and evaluation plan (data analysis).
• Results/Outcomes: Description of measurable outcomes achieved.
• Conclusions/Implications for Practice: Overview of how the project/initiative impacts clinical practice, systems, cost, and/or delivery of care. Discuss lessons learned and future plans (e.g., expansion or revision of project/initiative).

Innovation - Creative ideas, practices, products, and technology that provides new solutions to healthcare challenges. (Innovation Abstract Template)

• Background/Significance: Summary of the issue(s), problem, or specific clinical challenges or controversy, with relevant background and contextual information. Rationale for why innovation was needed. Supportive evidence synthesis and strength of the evidence, as applicable.
• Purpose/Goal: Statement of purpose or goal for the innovative project.
• Implementation Plan/Methods: Project description of process that led to development of innovation, process of implementation and evaluation.
• Results/Outcomes: Brief description of the outcomes.
• Conclusions/Implications for Practice: Brief description of implications for practice, lessons learned and next steps.

Abstract Review Criteria 

• Addresses essential components of the abstract
• Reflects current best evidence
• Relevance to current or future practice and work environment
• Overall contribution to the body of nursing knowledge
• Clarity of abstract, including, but not limited to comprehensiveness and readability
• Please Note: Abstracts will undergo a blind review process.

References 

• Suggest inclusion of 2-3 references (optional)
• Examples: evidence-based practice/peer review journals, clinical guidelines, best practices
• Current (not older than 5 years) unless classic, seminal work 
• If references are included, please follow American Psychological Association (APA) format guidelines for citing complete publication information.

Notification 

• The primary author of accepted presentations and posters will be notified on or around July 23, 2021. If your abstract is accepted, you will need to respond to the invitation by August 2, 2021, and register to attend the conference at a discounted price.

Key Dates 

• Submissions Deadline: July 2
• Acceptance/Rejection Notifications: July 23
• Presenter attendance confirmations: August 2
• Presenter registration deadline: August 24
• Presenter PowerPoint submission deadline: September 3

Questions regarding abstract submissions, please contact us at [email protected].